Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference

• Vincent BauchauGlaxoSmithKline (Belgium)
• Kaatje Bollaerts
• Philip T. BryanGlaxoSmithKline Research & Development Limited (United Kingdom)
• Jim P ButteryThe University of Melbourne
• Kourtney J. Davis
• Robert T. ChenThe Task Force for Global Health
• Daniel R. FeikinWorld Health Organization
• Antonella FrettaPfizer (United States)
• Sarah FriseAstraZeneca (Canada)
• Sonja Gandhi-BangaSanofi (Canada)
• Héctor S. IzurietaCenter for Biologics Evaluation and Research
• Corinne Jouquelet‐RoyerSanofi (France)
• Alena KhromavaSanofi (Canada)
• Lin LiSanofi (United States)
• Raj LongGates Foundation
• Sarah MacDonaldPfizer (United States)
• Lydie MarcelonSanofi (France)
• Robert MassouhGlaxoSmithKline Research & Development Limited (United Kingdom)
• Wilhelmine Hadler MeerausAstraZeneca (United Kingdom)
• Flor M. MuñozBaylor College of Medicine
• Karen NaimPfizer (United States)
• Dale F. Nordenberg
• Hanna NohynekFinnish Institute for Health and Welfare
• Heather RubinoPfizer (United States)
• Daniel A. SalmonJohns Hopkins University
• Sarah SellersNovavax (United States)
• Laurence SerradellSanofi (France)
• Laurence Torcel‐PagnonSanofi (France)
• Jamie WilkinsPfizer (United States)